May OPO Perfusion Expand Liver Use?
-
By
-
April 13, 2026
-
3 min
-
1
Portable hypothermic oxygenated machine perfusion (HMP-O2) was evaluated for liver transplants.
-
2
100% patient and graft survival at a median follow-up of 449 days.
-
3
67% of donors were donation-after-circulatory-death donors.
-
4
Early post-transplant complications were minimal.
-
5
Outcomes were consistent regardless of donor types.
-
6
Challenges included small sample size and single-center design.
-
7
Study funded by Organ Recovery Systems with authors having consulting relationships.